In addition, MUC4 is also overexpressed in breast, gastric and ovarian cancer [7-9], and its overexpression has been associated with the poor prognosis of pancreatic cancer and cholangiocarcinoma [10, 11]. Here, MUC4 is linked to familial pancreatic carcinoma.